Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance: retraction.

Journal of pediatric gastroenterology and nutrition·2013
Same author

DGAT1 mutation is linked to a congenital diarrheal disorder.

The Journal of clinical investigation·2012
Same author

Commentaries on "Workshop report: developing a pediatric inflammatory bowel diseases network and data platform in Canada": international networking in pediatric gastroenterology research: advancing science and medicine with collaborative efforts.

Journal of pediatric gastroenterology and nutrition·2012
Same author

Prevalence of celiac disease in an adult Jewish population in Israel.

The Israel Medical Association journal : IMAJ·2010
Same author

Prolidase deficiency: it looks like systemic lupus erythematosus but it is not.

European journal of pediatrics·2009
Same author

Nutritional solutions to major health problems of preschool children: how to optimise growth and development.

Journal of pediatric gastroenterology and nutrition·2007

Related Experiment Video

Updated: May 9, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

New insights in celiac disease.

David Branski1

  • 1Hadassah University Hospital, The Hebrew University Hadassah Medical School, Jerusalem, Israel; Editor-in-Chief, Journal of Pediatric Gastroenterology and Nutrition, Europe.

Rambam Maimonides Medical Journal
|August 3, 2013
PubMed
Summary

Celiac disease (CD) is an autoimmune disorder affecting 1% of the population. New treatments beyond a gluten-free diet (GFD) are needed due to adherence challenges and evolving clinical presentations.

Keywords:
Celiac diseaseglutenprobioticszonulin

More Related Videos

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component
07:39

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component

Published on: September 1, 2023

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Experiment Videos

Last Updated: May 9, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component
07:39

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component

Published on: September 1, 2023

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Area of Science:

  • Gastroenterology
  • Immunology
  • Genetics

Background:

  • Celiac disease (CD) is an autoimmune disorder in genetically susceptible individuals, affecting approximately 1% of the population.
  • While genetic factors are implicated, the inheritance pattern remains unclear, and environmental influences significantly impact disease presentation and characteristics.
  • CD presentation has evolved from classical gastrointestinal symptoms in toddlers to monosymptomatic presentations like anemia and extra-intestinal disorders in children.

Purpose of the Study:

  • To review the current understanding of celiac disease (CD) diagnosis and treatment.
  • To highlight the challenges associated with a lifelong gluten-free diet (GFD).
  • To explore emerging therapeutic strategies beyond the GFD for managing CD.

Main Methods:

  • Review of existing literature on celiac disease (CD) epidemiology, clinical presentation, diagnosis, and treatment.
  • Analysis of diagnostic criteria, including serology and histological evaluation.
  • Exploration of novel therapeutic approaches currently under development.

Main Results:

  • Diagnosis relies on symptoms, positive serology, and confirmed by small bowel biopsy.
  • Strict adherence to a gluten-free diet (GFD) is the current standard treatment but presents significant challenges.
  • Emerging therapies include modified baking techniques, probiotic-based enzymes, and zonulin activity modulation.

Conclusions:

  • New therapeutic strategies beyond a gluten-free diet (GFD) are crucial for improving celiac disease (CD) management.
  • These novel approaches aim to reduce gluten immunogenicity or enhance tolerance, potentially allowing occasional gluten consumption.
  • The future of CD treatment may involve a combination of GFD and innovative therapies.